Nevro CORP 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

4 Mar 2025

NVRO

10-K: Nevro Corp. Navigates Merger Amidst Market Challenges: 2024 10-K Report Highlights

Nevro Corp.'s 2024 10-K filing reveals a pending merger with Globus Medical, alongside financial results impacted by market headwinds and strategic shifts.

23 Feb 2024

NVRO

Nevro CORP

10-K: Nevro Corp. 10-K Filing: Strategic Growth and Market Expansion in Chronic Pain Treatment

Nevro Corp.'s 10-K filing highlights its focus on expanding its chronic pain solutions, including its HFX spinal cord stimulation platform and recent acquisition of Vyrsa Technologies.